We use cookies to analyze website usage and improve it. Some cookies are necessary for the website to function and cannot be switched off. Other cookies help us measure performance and collect anonymous data. You can opt in or opt out of specific non-essential cookies below.
In the same way that ChatGPT understands human language, a new AI model developed by Columbia computational biologists captures the language of cells to accurately predict their activities.
By generating movies of individual molecules performing actions that make our bodies tick, Columbia researchers have a deeper understanding of a process important in cancer and other diseases.
Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Misinformation and outdated beliefs about screening tests, treatment options, and effects on sexual health continue to cloud understanding about this disease.
The program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers who are at high risk for lung cancer and other complications.
Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.
Columbia cancer researchers estimate that 60% of patients in a phase 2 clinical trial will have no sign of their cancer two years after treatment with combination therapy.
Heavy ions could radically improve radiation therapy for cancer treatment, but research is needed to understand how they work. With the aid of a new instrument at Columbia, scientists aim to find out.
Columbia's Lisa A. Kachnic, MD, a pioneer in radiation oncology, discusses the advancements made in the field of radiotherapy and the innovation to come.